NYSE:OMI - Owens & Minor Stock Price, News, & Analysis

Owens & Minor trades on the New York Stock Exchange (NYSE) under the ticker symbol "OMI."

Owens & Minor declared a quarterly dividend on Monday, May 13th. Shareholders of record on Friday, June 14th will be paid a dividend of $0.0025 per share on Friday, June 28th. This represents a $0.01 annualized dividend and a yield of 0.36%. The ex-dividend date is Thursday, June 13th. View Owens & Minor's Dividend History.

Owens & Minor, Inc. (NYSE:OMI) posted its quarterly earnings results on Tuesday, May, 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.04 by $0.02. The company had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.45 billion. Owens & Minor had a negative net margin of 4.63% and a positive return on equity of 6.92%. The company's quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.43 earnings per share. View Owens & Minor's Earnings History.

Owens & Minor is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Owens & Minor.

Owens & Minor issued an update on its FY19 earnings guidance on Tuesday, May, 7th. The company provided earnings per share guidance of $0.60-0.75 for the period, compared to the Thomson Reuters consensus estimate of $0.66. Owens & Minor also updated its FY 2019 guidance to $0.60-0.75 EPS.

5 equities research analysts have issued twelve-month price objectives for Owens & Minor's shares. Their forecasts range from $4.50 to $9.00. On average, they expect Owens & Minor's share price to reach $6.70 in the next year. This suggests a possible upside of 138.4% from the stock's current price. View Analyst Price Targets for Owens & Minor.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Owens & Minor.

News headlines about OMI stock have been trending somewhat positive recently, InfoTrie reports. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Owens & Minor earned a news impact score of 1.4 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Owens & Minor.

Some companies that are related to Owens & Minor include Vericel (VCEL), Hanger (HNGR), Advanced Medical Solutions Group (AMS), Estia Health (EHE), G1 Therapeutics (GTHX), Twist Bioscience (TWST), Intra-Cellular Therapies (ITCI), Mesoblast (MSB), Clovis Oncology (CLVS), Adverum Biotechnologies (ADVM), MeiraGTx (MGTX), CannTrust (CTST), Avita Medical (AVH), Organogenesis (ORGO) and Arvinas (ARVN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Owens & Minor investors own include AT&T (T), Micron Technology (MU), AbbVie (ABBV), Cisco Systems (CSCO), Alibaba Group (BABA), Omega Healthcare Investors (OHI), Applied Materials (AMAT), 3M (MMM), Tanger Factory Outlet Centers (SKT) and Simon Property Group (SPG).

Owens & Minor's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include JPMorgan Chase & Co. (4.64%), LSV Asset Management (2.99%), Royce & Associates LP (2.15%), Smith Graham & Co. Investment Advisors LP (1.28%), SG Americas Securities LLC (1.04%) and Brandes Investment Partners LP (0.64%). Company insiders that own Owens & Minor stock include Charles C Colpo and Geoff Taylor Marlatt. View Institutional Ownership Trends for Owens & Minor.

OMI stock was sold by a variety of institutional investors in the last quarter, including Brandes Investment Partners LP, LSV Asset Management, North Star Investment Management Corp., Rhumbline Advisers, Gamco Investors INC. ET AL, Inlet Private Wealth LLC, JPMorgan Chase & Co. and Smith Graham & Co. Investment Advisors LP. Company insiders that have sold Owens & Minor company stock in the last year include Charles C Colpo and Geoff Taylor Marlatt. View Insider Buying and Selling for Owens & Minor.

OMI stock was acquired by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Royce & Associates LP, Acadian Asset Management LLC, Cardinal Capital Management, Nisa Investment Advisors LLC, Spark Investment Management LLC, NumerixS Investment Technologies Inc and Campbell & CO Investment Adviser LLC. View Insider Buying and Selling for Owens & Minor.

Shares of OMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of OMI stock can currently be purchased for approximately $2.81.

Owens & Minor has a market capitalization of $176.86 million and generates $9.84 billion in revenue each year. The company earns $-437,010,000.00 in net income (profit) each year or $1.15 on an earnings per share basis. Owens & Minor employs 17,900 workers across the globe.View Additional Information About Owens & Minor.

The official website for Owens & Minor is http://www.owens-minor.com/.

Owens & Minor's mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company can be reached via phone at 804-723-7000 or via email at [email protected]